Stadium, originally recommended by Growth Company Investor at 36.5p in 2002, continues to play its part in the ongoing consolidation of the UK electronic manufacturing services sector.
Its latest acquisition is that of Rugby-based Zirkon, purchased for a net-cash consideration of £2.5m and bringing additional ‘high technology market experience' in sectors including industrial instrumentation and medical. In the year to June, Zirkon, described as ‘a perfect fit’ with Stadium’s operational model and growth strategy, made profits of £600,000 on turnover of £7.3m.
In September Stadium, whose core business is the design and manufacture of electronic and power supply products for OEMs from facilities in the UK and China, acquired Fox Industries for £100,000 in cash. Fox added further strings to the Stadium bow, being a profitable designer and distributor of specialist power supplies for the military, medical and industrial sectors.
So far, Stadium appears to be wearing the combined challenges of economic slowdown and rising energy and commodity prices well. Results for the half to June revealed a creditable 13% increase in pre-tax profits to £1.4m, on turnover lifted 16% to £23.1m, with strong cash conversion enabling a reduction in borrowings.
Based on forecasts for the current year to December – profits of £2.8m, earnings of 7.7p and a likely 3.9p dividend – shares in Stadium trade on a forward p/e of only 6.5 and offer a bumper yield of 7.8%. They remain worth holding for steady growth and income.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £14.4m
PE Forecast: 6.5
Share price: 50p
Growth Company Investor is the leading magazine for investors in AIM and boasts award-winning research and analysis coverage.
Subscribe now and receive a 50% discount
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Staff rostering software specialist Allocate, buoyed by 27% organic growth in the six months to November, aims to speed expansion with several acquisitions in coming years.
Growing organically and through acquisitions, Chloride represents a compelling play on essential international spend on secure power.
StatPro, the portfolio analytics and data solutions provider for the global fund management industry, continues to win deals and build its repeat revenue base.